CAPTOR THHERAP. ZY-,10 Share · PLCPTRT00014 · A3CNAX (XWAR) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of CAPTOR THHERAP. ZY-,10

No Price

Closing Price XWAR 30.04.2026: 78,80 PLN

30.04.2026 17:31

Current Prices from CAPTOR THHERAP. ZY-,10

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
Düsseldorf	CTSAIA14.DUSB	EUR	30.04.2026 17:31	18,44 EUR	-
WSE	CTX.WA	PLN	30.04.2026 15:00	78,80 PLN	-1,70 PLN -2,11 %
Quotrix	CTSAIA14.DUSD	EUR	30.04.2026 05:27	18,74 EUR	-

Share Float & Liquidity

Free Float 69,02 %

Shares Float 3,8 M

Shares Outstanding 5,51 M

Company Profile for CAPTOR THHERAP. ZY-,10 Share

Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five projects at the preclinical stage. The company was incorporated in 2015 and is based in Wroclaw, Poland.